| 2025-09-15 | -54.5% | news | Quiver Quantitative | Bionano Laboratories Announces CMS Preliminary Payment Determination for Optical Genome Mapping CPT Code - Quiver Quantitative |
| 2025-09-16 | -35.8% | news | Seeking Alpha | Bionano Genomics slides after pricing $10M equity offering |
| 2025-09-16 | -35.8% | news | Quiver Quantitative | Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering of Common Stock and Warrants - Quiver Quantitative |
| 2025-04-01 | +33.5% | earnings | Seeking Alpha | Bionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilization |
| 2025-04-01 | +33.5% | earnings | Seeking Alpha | Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript |
| 2023-04-17 | -31.6% | news | GlobeNewswire | Bionano Genomics Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire |
| 2026-03-20 | +31.0% | earnings | Benzinga | Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings C - Benzinga |
| 2021-05-14 | +25.7% | analyst | Benzinga | Bionano Genomics Analyst Ratings and Price Targets | NASDAQ:BNGO - Benzinga |
| 2024-08-07 | -23.2% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2023-04-14 | -22.5% | legal | SEC EDGAR | BNGO 8-K: 1.01, 3.02, 3.03, 5.03 (SEC Filing) |
| 2026-03-24 | -18.0% | earnings | GuruFocus.com | Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... |
| 2026-03-24 | -18.0% | earnings | Moby | Bionano Genomics, Inc. Q4 2025 Earnings Call Summary |
| 2026-03-24 | -18.0% | earnings | Seeking Alpha | Bionano Genomics, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-03-24 | -18.0% | earnings | Seeking Alpha | Bionano Genomics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:BNGO) 2026-03-24 - Seeking Alpha |
| 2026-03-24 | -18.0% | earnings | GuruFocus | Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Na - GuruFocus |
| 2023-10-11 | -17.4% | legal | SEC EDGAR | BNGO 8-K: 1.01, 2.02, 2.03, 2.05, 3.02, 7.01 (SEC Filing) |
| 2024-10-31 | -16.1% | legal | SEC EDGAR | BNGO 8-K: 1.01, 7.01, 8.01 (SEC Filing) |
| 2023-08-14 | -15.7% | legal | SEC EDGAR | BNGO 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-01-06 | -15.1% | legal | SEC EDGAR | BNGO 8-K: 1.01, 7.01, 8.01 (SEC Filing) |
| 2025-09-09 | +15.0% | news | Seeking Alpha | Bionano Genomics, Inc. (BNGO) Presents At H.C. Wainwright 27th Annual Global Investment Conference Prepared Remarks Transcript |
| 2024-01-09 | -13.9% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-01-30 | -13.8% | earnings | simplywall.st | Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues - simplywall.st |
| 2022-11-28 | -12.6% | legal | SEC EDGAR | BNGO 8-K: 1.01, 7.01, 8.01 (SEC Filing) |
| 2022-11-18 | -12.6% | legal | SEC EDGAR | BNGO 8-K: 5.02 (SEC Filing) |
| 2024-07-08 | +12.5% | legal | SEC EDGAR | BNGO 8-K: 1.01, 3.02, 7.01, 8.01 (SEC Filing) |
| 2024-10-10 | -12.3% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2021-07-13 | -12.1% | earnings | Zacks Investment Research | What date does Bionano Genomics's (BNGO) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2022-05-05 | -12.0% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2021-05-13 | +11.2% | legal | SEC EDGAR | BNGO 8-K: 2.02, 8.01 (SEC Filing) |
| 2021-11-04 | -10.6% | legal | SEC EDGAR | BNGO 8-K: 2.02, 8.01 (SEC Filing) |
| 2023-04-24 | +10.3% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2025-09-08 | +9.3% | news | Yahoo Finance | Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock - Yahoo Finance |
| 2022-08-16 | -9.2% | analyst | TradingView | BNGO Forecast — Price Target — Prediction for 2027 - TradingView |
| 2025-01-13 | -9.0% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2025-01-13 | -9.0% | news | Intellectia AI | BNGO Forecast — Price Prediction for 2026. Should I Buy BNGO? - Intellectia AI |
| 2023-02-03 | -8.5% | legal | SEC EDGAR | BNGO 8-K: 2.02 and 8.01 (SEC Filing) |
| 2025-02-10 | -8.3% | expansion | Investing.com | Bionano Genomics ends sales agreement with Cowen - Investing.com |
| 2024-05-28 | -7.8% | legal | SEC EDGAR | BNGO 8-K: 1.01, 1.02, 2.03, 3.02, 7.01, 8.01 (SEC Filing) |
| 2022-10-26 | -7.7% | news | InvestorPlace | What Is Going on With Bionano Genomics (BNGO) Stock Today? - InvestorPlace |
| 2025-11-12 | -7.7% | earnings | Seeking Alpha | Bionano Genomics Q3 2025 Earnings Preview |
| 2022-12-06 | +7.6% | news | The Motley Fool | 3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street - The Motley Fool |
| 2022-02-23 | +7.4% | legal | SEC EDGAR | BNGO 8-K: 5.02 (SEC Filing) |
| 2024-05-11 | +7.3% | earnings | MarketBeat | Bionano Genomics (BNGO) Stock Forecast and Price Target 2026 - MarketBeat |
| 2022-08-04 | +6.9% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2023-05-09 | +6.8% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2023-11-08 | -6.3% | legal | SEC EDGAR | BNGO 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-01-12 | -6.2% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2024-04-05 | +6.0% | legal | SEC EDGAR | BNGO 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-08-14 | -5.9% | earnings | Seeking Alpha | Earnings Snapshot: Bionano Genomics guides Q3, full year revenue below consensus |
| 2025-08-14 | -5.9% | earnings | Seeking Alpha | Bionano Genomics reports Q2 results |
| 2025-08-14 | -5.9% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2025-08-14 | -5.9% | earnings | Investing.com | Earnings call transcript: Bionano Genomics Q2 2025 sees revenue drop, stock dips - Investing.com |
| 2025-03-31 | +5.9% | earnings | Seeking Alpha | Earnings Snapshot: Bionano Genomics beats on topline in Q4 |
| 2025-03-31 | +5.9% | earnings | Seeking Alpha | Bionano Genomics reports Q4 results |
| 2025-03-31 | +5.9% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2025-01-03 | +5.9% | legal | SEC EDGAR | BNGO 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2025-01-16 | -5.8% | news | Investing.com | Bionano Genomics shareholders approve stock issuance and reverse split - Investing.com |
| 2022-03-18 | +5.8% | news | InvestorPlace | Bionano Genomics May Finally Offer a Reward for Your Risk - InvestorPlace |
| 2025-03-26 | -5.5% | news | Investing.com UK | BNGO stock touches 52-week low at $3.15 amid market challenges - Investing.com UK |
| 2021-08-04 | +5.3% | legal | SEC EDGAR | BNGO 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-05-13 | -5.1% | earnings | Seeking Alpha | Bionano Genomics Q1 Earnings Preview |
| 2023-03-09 | -5.1% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2025-11-24 | +5.0% | analyst | Benzinga | Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga |
| 2025-02-21 | -5.0% | legal | SEC EDGAR | BNGO 8-K: 1.01 and (SEC Filing) |
| 2025-03-18 | -4.9% | news | Investing.com UK | BNGO stock touches 52-week low at $3.28 amid market challenges - Investing.com UK |
| 2021-10-12 | +4.8% | legal | SEC EDGAR | BNGO 8-K: 1.01, 3.02, 7.01, 8.01 (SEC Filing) |
| 2021-10-12 | +4.8% | M&A | InvestorPlace | BNGO Stock: The Big Acquisition News Sending Bionano Genomics Soaring - InvestorPlace |
| 2026-04-03 | -4.6% | legal | Cổng thông tin điện tử tỉnh Tây Ninh | BNGO Stock Analysis: Bionano Genomics Inc. holds 1.2 level with mild daily gain in genomics sector - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2022-11-29 | -4.4% | legal | SEC EDGAR | BNGO 8-K: 8.01 and (SEC Filing) |
| 2025-06-13 | -4.1% | legal | SEC EDGAR | BNGO 8-K: 5.02 and 5.07 (SEC Filing) |
| 2026-02-04 | -4.1% | news | Stock Titan | New gene editing safety check uses Bionano tech to spot hidden DNA changes - Stock Titan |
| 2024-02-28 | -4.1% | legal | SEC EDGAR | BNGO 8-K: 1.01, 7.01 (SEC Filing) |
| 2023-07-24 | -4.1% | news | Seeking Alpha | Bionano Genomics: A Noble Cause But A Bad Investment (BNGO) - Seeking Alpha |
| 2026-04-02 | -3.9% | analyst | GlobeNewswire | Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma |
| 2026-04-02 | -3.9% | earnings | Stock Titan | In 211 myeloma samples, OGM found abnormalities older tests missed - Stock Titan |
| 2025-08-13 | +3.9% | earnings | Seeking Alpha | Bionano Genomics Q2 2025 Earnings Preview |
| 2025-05-08 | +3.5% | news | Capital.com | Bionano Genomics, Inc. (BNGO) Stock Price Quote Today & Current Price Chart - Capital.com |
| 2025-11-13 | -3.3% | earnings | Seeking Alpha | Bionano jumps 6% on Q3 revenue beat, 2025 guidance range |
| 2025-11-13 | -3.3% | earnings | Seeking Alpha | Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus |
| 2025-11-13 | -3.3% | earnings | Seeking Alpha | Bionano Genomics reports Q3 results |
| 2025-11-13 | -3.3% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2025-11-13 | -3.3% | earnings | Yahoo Finance | Bionano Genomics Inc (BNGO) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Cost ... - Yahoo Finance |
| 2025-11-13 | -3.3% | earnings | TradingView | Bionano Genomics Q3 2025 Financial Results - TradingView |
| 2023-01-05 | -3.1% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2024-01-08 | -3.1% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2025-11-14 | +3.0% | earnings | Seeking Alpha | Bionano Genomics, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-14 | +3.0% | earnings | Seeking Alpha | Bionano reiterates $26M–$30M 2025 revenue guidance as core consumables and software sales grow 15% year over year |
| 2025-11-14 | +3.0% | earnings | Seeking Alpha | Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript |
| 2024-04-08 | +2.8% | legal | SEC EDGAR | BNGO 8-K: 8.01 and (SEC Filing) |
| 2026-02-25 | +2.4% | news | GlobeNewswire | 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy |
| 2022-11-03 | +2.3% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2022-07-28 | -2.2% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Bionano Genomics (BNGO) - Zacks Investment Research |
| 2025-09-21 | -2.1% | expansion | Yahoo Finance | Bionano Genomics Launches $10 Million Public Offering - Yahoo Finance |
| 2026-03-17 | +2.0% | news | GlobeNewswire | Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting |
| 2026-03-23 | +1.9% | earnings | Motley Fool | Bionano Genomics (BNGO) Earnings Transcript |
| 2026-03-23 | +1.9% | earnings | GlobeNewswire | Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 |
| 2026-03-23 | +1.9% | earnings | Seeking Alpha | Bionano outlines $30M–$33M revenue target for 2026 with focus on routine user growth and margin expansion |
| 2026-03-23 | +1.9% | earnings | Seeking Alpha | Bionano Genomics, Inc. (BNGO) Q4 2025 Earnings Call Transcript |
| 2026-03-23 | +1.9% | earnings | Seeking Alpha | Earnings Snapshot: Bionano Genomics beats Q4 top-line but guides Q1, FY25 revenue below estimates |
| 2026-03-23 | +1.9% | earnings | Seeking Alpha | Bionano Genomics reports Q4 results |
| 2026-03-23 | +1.9% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2026-03-23 | +1.9% | news | Benzinga | Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story - Benzinga |
| 2026-03-23 | +1.9% | earnings | Investing.com | Earnings call transcript: Bionano Genomics’ Q4 2025 results show cost cuts, stock surges - Investing.com |
| 2026-03-23 | +1.9% | earnings | GlobeNewswire | Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 - GlobeNewswire |
| 2026-03-23 | +1.9% | news | Benzinga | United Airlines, AGI And 3 Stocks To Watch Heading Into Monday - United Airlines Holdings (NASDAQ:UAL) - Benzinga |
| 2023-03-13 | +1.8% | legal | SEC EDGAR | BNGO 8-K: 8.01 (SEC Filing) |
| 2023-03-13 | +1.8% | earnings | TradingView | Bionano Genomics, Inc. Earnings and Revenue – NASDAQ:BNGO - TradingView |
| 2025-08-22 | -1.8% | news | Yahoo Finance | Bionano Genomics (BNGO) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance |
| 2026-04-01 | +1.7% | news | Cổng thông tin điện tử Tỉnh Sơn La | BNGO Stock Analysis: Bionano Genomics Inc logs 1.71 pct gain to 1.19 in biotech - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-08-15 | -1.6% | earnings | Seeking Alpha | Bionano raises 2025 OGM installation target to 25 as consumables and software revenue climbs 16% |
| 2025-08-15 | -1.6% | earnings | Seeking Alpha | Bionano Genomics, Inc. 2025 Q2 - Results - Earnings Call Presentation |
| 2025-08-15 | -1.6% | earnings | Seeking Alpha | Bionano Genomics, Inc. (BNGO) Q2 2025 Earnings Call Transcript |
| 2025-08-15 | -1.6% | earnings | Yahoo Finance | Bionano Genomics Inc (BNGO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance |
| 2024-09-09 | -1.6% | legal | SEC EDGAR | BNGO 8-K: 2.05, 5.02, 7.01 (SEC Filing) |
| 2021-10-19 | +1.5% | legal | SEC EDGAR | BNGO 8-K: 2.01 and (SEC Filing) |
| 2026-02-09 | +1.5% | news | Stock Titan | Global scientists converge online to map genomes at Bionano’s 4-day summit - Stock Titan |
| 2024-05-08 | +1.5% | legal | SEC EDGAR | BNGO 8-K: 2.02, 2.05 (SEC Filing) |
| 2025-05-20 | -1.2% | analyst | GuruFocus | Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brig - GuruFocus |
| 2022-11-30 | +1.1% | legal | SEC EDGAR | BNGO 8-K: 2.01 (SEC Filing) |
| 2025-05-14 | -1.1% | earnings | Seeking Alpha | Bionano outlines $26M–$30M 2025 revenue target as strategic pivot drives higher gross margin |
| 2025-05-14 | -1.1% | earnings | Seeking Alpha | Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript |
| 2025-05-14 | -1.1% | earnings | Seeking Alpha | Bionano Genomics stock rises on Q1 revenue beat |
| 2025-05-14 | -1.1% | earnings | Seeking Alpha | Bionano Genomics reports Q1 results |
| 2025-05-14 | -1.1% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2022-03-01 | +1.1% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | +1.0% | news | GlobeNewswire | 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders |
| 2021-10-27 | -0.9% | news | Benzinga | Bionano Genomics Stock Short Interest Report | NASDAQ:BNGO - Benzinga |
| 2022-04-13 | -0.8% | news | Nanalyze | Bionano Genomics Stock: What Exactly Do They Do? - Nanalyze |
| 2024-11-13 | +0.6% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2024-11-13 | +0.6% | earnings | Yahoo Finance | Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance |
| 2024-03-05 | +0.5% | legal | SEC EDGAR | BNGO 8-K: 2.02, 2.05 (SEC Filing) |
| 2026-02-27 | -0.4% | news | GlobeNewswire | Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale |
| 2025-09-18 | +0.4% | legal | SEC EDGAR | BNGO 8-K: 1.01, 8.01 (SEC Filing) |
| 2024-10-16 | -0.4% | news | Investing.com | Bionano Genomics stock hits 52-week low at $0.3 amid market challenges - Investing.com |
| 2025-11-16 | -0.4% | expansion | marketscreener.com | 4,755,265 Common Stock of Bionano Genomics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2025. - marketscreener.com |
| 2023-08-09 | +0.4% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2025-05-15 | +0.2% | news | Seeking Alpha | Biggest stock movers Thursday: UNH, CSCO, NTES, FL, BABA, and more |
| 2021-12-23 | -0.2% | legal | SEC EDGAR | BNGO 8-K: 5.02 (SEC Filing) |
| 2021-12-30 | +0.2% | legal | SEC EDGAR | BNGO 8-K: 1.01 (SEC Filing) |
| 2026-02-24 | +0.2% | news | Stock Titan | Scientists from 70 countries explore new DNA mapping tools for blood cancers - Stock Titan |
| 2026-03-09 | +0.2% | news | GlobeNewswire | Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 |
| 2026-03-09 | +0.2% | news | GlobeNewswire | Bionano to Report Fourth Quarter and Full Year 2025 - GlobeNewswire |
| 2026-02-14 | -0.2% | news | Stock Titan | BNGO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan |
| 2026-01-12 | +0.0% | legal | SEC EDGAR | BNGO 8-K: 2.02 and (SEC Filing) |
| 2026-01-12 | +0.0% | news | Stock Titan | Genome mapping company says 2025 sales slipped despite more systems - Stock Titan |
| 2026-04-07 | +0.0% | analyst | Cổng thông tin điện tử Tỉnh Sơn La | Is Bionano (BNGO) Stock Stronger Than Peers | Price at $1.17, Up 1.74% - Top Analyst Buy Signals - Cổng thông tin điện tử Tỉnh Sơn La |